| 3004.10.10 | 45 | Combination antibiotics | kg | | | |
| 3004.10.50 | 45 | Combination antibiotics | kg | | | |
| 3004.20.00 | | Containing other antibiotics | | Free | | 25% |
| 3004.20.00 | 20 | Erythromycin, singles or in combination with other antibiotics | kg | | | |
| 3004.20.00 | 30 | Tetracycline, singles or in combination with other antibiotics | kg | | | |
| 3004.31.00 | 00 | Containing hormones or other products of heading 2937 but not containing antibiotics: | | | | |
| 3004.31.00 | 00 | Containing insulin | kg | Free | | 25% |
| 3004.32.00 | 00 | Containing corticosteroid hormones, their derivatives or structural analogues | kg | Free | | 25% |
| 3004.40.00 | | Containing alkaloids or derivatives thereof but not containing hormones, other products of heading 2937 or antibiotics | | Free | | 25% |
| 3004.40.00 | 10 | Cardiovascular medicaments | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 20 | Anticonvulsants, hypnotics, and sedatives | kg | | | |
| 3004.40.00 | 30 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | | | |
| 3004.40.00 | 50 | Dermatological agents and local anesthetics | kg | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.50 | | Other medicaments containing vitamins or other products of heading 2936: | | | | |
| 3004.50.10 | 00 | Containing vitamins synthesized wholly or in part from aromatic or modified aromatic industrial organic compounds: | | | | |
| 3004.50.50 | 10 | Combined with minerals or other nutrients | kg | | | |
| 3004.50.50 | 30 | Combined with minerals or other nutrients | kg | | | |
| 3004.90.10 | 00 | Containing antigens or hyaluronic acid or its sodium salt | kg | Free | | Free |
| 3004.90.91 | 05 | Anti-infective medicaments: | | | | |
| 3004.90.91 | 80 | Antihistamines | kg | | | |
| 3004.90.91 | 15 | Antineoplastic and immunosuppressive medicaments | kg | | | |
| 3004.90.91 | 20 | Cardiovascular medicaments | kg | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
